Introduction
Diabetic peripheral neuropathy (DPN) is one of the most common and debilitating microvascular complications of diabetes, with no currently effective options for therapeutic treatment [1] [2] [3] . The pathogenesis of DPN remains elusive; however, Schwann cells, myelinating cells of the peripheral nervous system, have been shown to play an important role in the pathogenesis and development of DPN [4] . Besides their roles in myelination, trophic support, and the regeneration of axons, Schwann cells exhibit immune functions, similar to the non-myelinating glia of the central nervous system (CNS) [5, 6] . These functions include the production of chemokines and cytokines, the expression of major histocompatibility complex (MHC) class II molecules and adhesion molecules, and serving as antigen presenting cells caused by hyperglycemia can cause nerve dysfunctions, such as reduced nerve conduction velocity, axonal atrophy, and impaired axonal regeneration [4, 9, 10] . However, answers for how abnormalities of Schwann cells are caused have remained elusive.
Previous studies have shown that monocytes/macrophages/T cells play key roles in the it has been reported that macrophages play an important role in the progression of diabetic + T cells recognize antigens through MHC class I molecules and are predominantly cytotoxic T cells with various mechanisms to kill their targets, including direct cell-cell signaling via surface molecules and Whereas whether T cells participates in the progression of diabetic neuropathy has not been investigate clearly.
) and that their expression tissues plays a critical role in the development of DPN, it is important to investigate whether 
Materials and Methods

Sample preparation
Human peripheral blood samples were collected from patients with a clinical diagnosis of diabetes and DPN as well as healthy individuals at Shanghai Changzheng Hospital. The clinical diagnostic criterias for diabetics and DPN were performed as follows. The diagnostic criteria for diabetes mellitus (DM): Total proteins extracted from PBMCs were searches against the NCBInr database using the UK) or http://www.matrixscience.com). The hyperglycemic state is a major risk factor for the development of DPN and acts deleteriously via several pathways, including the adipose reduction pathway, the advanced glycation end product pathway, the reactive oxygen intermediate pathway and PKC pathway, mediators that give rise to deleterious effects, both systemically and locally in tissues [16] . Diabetes is a major cause of peripheral neuropathy and is associated with changes in several metabolic and vascular mechanisms. In diabetes, macrophages activated by such as interleukin-1, interleukin-6, leukemia inhibitory factor, ciliary neurotropic factor, tumor necrosis factor, and transforming growth factor, resulting in endothelial and nerve 
